Compared with the calcium carbonate nanoparticles containing nonspecific siRNA, nanoparticles with siRNA-targeting VEGF-C showed higher transfection efficiency in the human gastric cancer cell line SGC-7901, which was demonstrated by an ~80% decrease in the concentration of VEGF mRNA and VEGF-C. The gene discussed is VEGFC; the disease is gastric cancer.